Stratasys Ltd Financials
Stratasys Ltd (SSYS) reported $551.1M in revenue for fiscal year 2025, down 3.7% from the prior fiscal year. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 15 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
Cost cutting and working-capital release are cushioning losses, while shrinking revenue still keeps Stratasys from self-funding.
FY2025’s earnings quality was better than headline losses suggest: a net loss of-$104.3M still converted into$15.1M of operating cash flow. That cash lift coincided with working-capital release as inventory shrank19.2% from FY2024, but free cash flow remained-$7.0M , so the business generated cash before reinvestment, not after it.
The operating loss narrowed to
The balance sheet remains lightly burdened by liabilities: total liabilities were only
Financial Health Signals
Scored against operating companies for FY2025. Each of the six dimensions is a percentile rank within that peer group; the overall is their average, with missing dimensions counted as zero out of six. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →
Health score ≠ stock price. This rates the quality of Stratasys Ltd's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.
Stratasys Ltd has an operating margin of -13.2%, meaning the company loses $13 on every $100 of revenue. This results in a profitability score of 38/100. This is up from -15.0% the prior year.
Stratasys Ltd's revenue declined 3.7% year-over-year, from $572.5M to $551.1M. This contraction results in a growth score of 15/100.
Stratasys Ltd carries a low D/E ratio of 0.27, meaning only $0.27 of long-term debt for every $1 of shareholders' equity. This conservative leverage earns a score of 70/100, indicating a strong balance sheet with room for future borrowing.
With a current ratio of 3.57, Stratasys Ltd holds $3.57 in current assets for every $1 of short-term obligations. This comfortable liquidity earns a score of 83/100.
While Stratasys Ltd generated $15.1M in operating cash flow, capex of $22.1M consumed most of it, leaving -$7.0M in free cash flow. This results in a low score of 22/100, reflecting heavy capital investment rather than weak cash generation.
Stratasys Ltd posts a -12.4% return on equity (ROE), meaning it loses $12 for every $100 of shareholders' equity. This results in a returns score of 40/100. This is up from -15.2% the prior year.
Stratasys Ltd scores -0.46, below the 1.81 distress threshold. The score is driven primarily by a large market capitalization ($746.6M) relative to total liabilities ($230.9M). This indicates elevated financial distress risk and warrants close attention to liquidity and debt levels.
Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.
Stratasys Ltd passes 4 of 8 computable financial strength tests (1 of the nine could not be computed from available data). 3 of 4 profitability signals pass, 1 of 2 leverage/liquidity signals pass, neither operating efficiency signal passes.
Stratasys Ltd reported a net loss of $104.3M while generating $15.1M in operating cash flow. Operations generated cash despite the loss, but with no positive earnings behind it, the ratio between the two carries no quality signal.
Key Financial Metrics
Earnings & Revenue
Stratasys Ltd generated $551.1M in revenue in fiscal year 2025. This represents a decrease of 3.7% from the prior year.
Stratasys Ltd's EBITDA was -$29.3M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization. This represents an increase of 27.3% from the prior year.
Stratasys Ltd reported -$104.3M in net income in fiscal year 2025. This represents an increase of 13.3% from the prior year.
Not reported for fiscal year 2025.
Cash & Balance Sheet
Stratasys Ltd recorded an outflow of $7.0M in free cash flow in fiscal year 2025, representing a cash shortfall after capex. This represents a decrease of 128.6% from the prior year.
Stratasys Ltd held $94.5M in cash as of fiscal year 2025; long-term debt is not reported for that period.
Not reported for fiscal year 2025.
Margins & Returns
Stratasys Ltd's gross margin was 41.2% in fiscal year 2025, indicating the percentage of revenue retained after direct costs. This is down 3.6 percentage points from the prior year.
Stratasys Ltd's operating margin was -13.2% in fiscal year 2025, reflecting core business profitability. This is up 1.8 percentage points from the prior year.
Stratasys Ltd's net profit margin was -18.9% in fiscal year 2025, showing the share of revenue converted to profit. This is up 2.1 percentage points from the prior year.
Stratasys Ltd's ROE was -12.4% in fiscal year 2025, measuring profit generated per dollar of shareholder equity. This is up 2.8 percentage points from the prior year.
Capital Allocation
Stratasys Ltd invested $77.3M in research and development in fiscal year 2025. This represents a decrease of 22.0% from the prior year.
Stratasys Ltd invested $22.1M in capex in fiscal year 2025, funding long-term assets and infrastructure. This represents an increase of 103.4% from the prior year.
Not reported for fiscal year 2025.
SSYS Income Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.
| Metric | FY25 | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $551.1M-3.7% | $572.5M-8.8% | $627.6M-3.7% | $651.5M+7.3% | $607.2M+16.6% | $520.8M-18.1% | $636.1M-4.1% | $663.2M-0.8% | $668.4M-0.6% | $672.5M-3.4% | $696.0M-7.2% | $750.1M+54.9% | $484.4M+125.0% | $215.2M+38.1% | $155.9M |
| Cost of Revenue | $323.8M+2.6% | $315.6M-12.5% | $360.6M-3.9% | $375.0M+8.0% | $347.1M+15.2% | $301.4M-6.5% | $322.4M-4.6% | $338.0M-2.2% | $345.6M-2.7% | $355.2M-40.2% | $593.8M+53.2% | $387.7M+50.2% | $258.2M+145.2% | $105.3M+43.3% | $73.5M |
| Gross Profit | $227.3M-11.5% | $256.8M-3.8% | $267.0M-3.4% | $276.5M+6.3% | $260.1M+18.5% | $219.4M-30.1% | $313.7M-3.5% | $325.2M+0.8% | $322.8M+1.7% | $317.3M+210.6% | $102.2M-71.8% | $362.4M+60.2% | $226.2M+105.8% | $109.9M+33.4% | $82.4M |
| R&D Expenses | $77.3M-22.0% | $99.1M+5.0% | $94.4M+1.7% | $92.9M+5.2% | $88.3M+5.1% | $84.0M-10.9% | $94.3M-4.8% | $99.0M+2.8% | $96.2M-1.6% | $97.8M-20.1% | $122.4M+48.7% | $82.3M+57.3% | $52.3M+166.1% | $19.7M+36.9% | $14.4M |
| SG&A Expenses | $222.5M-8.6% | $243.3M-6.5% | $260.2M+8.1% | $240.8M-4.1% | $250.9M+22.3% | $205.2M-11.2% | $231.1M-1.7% | $235.1M | N/A | N/A | N/A | N/A | $7.6M0.0% | $7.6M | N/A |
| Operating Income | -$72.5M+15.4% | -$85.7M+2.2% | -$87.6M-53.2% | -$57.2M+27.8% | -$79.2M+82.6% | -$456.0M-3797.7% | -$11.7M-32.2% | -$8.8M+71.0% | -$30.5M+64.8% | -$86.7M+93.7% | -$1.4B-826.9% | -$148.2M-412.2% | -$28.9M-269.0% | $17.1M-41.0% | $29.0M |
| Income Tax | $3.1M+3.7% | $3.0M-48.6% | $5.8M+6.0% | $5.5M+239.6% | -$3.9M+76.2% | -$16.4M-565.3% | $3.5M-25.6% | $4.7M-48.9% | $9.3M+198.2% | -$9.4M+8.5% | -$10.3M+70.7% | -$35.2M-1324.7% | -$2.5M-125.5% | $9.7M-9.7% | $10.7M |
| Net Income | -$104.3M+13.3% | -$120.3M+2.3% | -$123.1M-324.8% | -$29.0M+53.3% | -$62.0M+86.0% | -$443.7M-3990.0% | -$10.8M+1.0% | -$11.0M+72.6% | -$40.0M+48.2% | -$77.2M+94.4% | -$1.4B-1049.6% | -$119.4M-343.1% | -$27.0M-417.4% | $8.5M-58.8% | $20.6M |
| EPS (Diluted) | N/A | N/A | N/A | -$0.44+55.1% | -$0.98+87.9% | -$8.08-3940.0% | -$0.20+9.1% | -$0.22+70.7% | -$0.75+49.3% | -$1.48+94.4% | -$26.64-1014.6% | -$2.39-251.5% | -$0.68 | $0.36-62.1% | $0.95 |
Not reported in any period shown, so not listed: Interest Expense.
SSYS Balance Sheet
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.
| Metric | FY25 | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | $1.1B+4.3% | $1.0B-9.2% | $1.1B-10.0% | $1.3B-1.4% | $1.3B+29.0% | $990.0M-28.3% | $1.4B-0.5% | $1.4B+0.6% | $1.4B+1.0% | $1.4B-3.4% | $1.4B-51.2% | $2.9B+4.2% | $2.8B+60.7% | $1.7B+680.8% | $221.8M |
| Current Assets | $582.0M+13.5% | $513.0M-8.4% | $560.1M-20.0% | $700.2M-12.5% | $800.7M+42.9% | $560.5M-15.0% | $659.1M-3.7% | $684.2M+11.3% | $614.9M+11.2% | $553.0M+1.1% | $547.1M-31.3% | $796.6M-6.5% | $852.1M+163.6% | $323.3M+246.8% | $93.2M |
| Cash & Equivalents | $94.5M+34.7% | $70.2M-15.0% | $82.6M-45.1% | $150.5M-38.1% | $243.2M-10.6% | $272.1M-7.3% | $293.5M-25.4% | $393.2M+19.6% | $328.8M+17.3% | $280.3M+8.8% | $257.6M-41.7% | $442.1M+6.8% | $414.1M+209.4% | $133.8M+566.1% | $20.1M |
| Inventory | $145.2M-19.2% | $179.8M-6.8% | $193.0M-0.6% | $194.1M+50.3% | $129.1M-1.9% | $131.7M-21.9% | $168.5M+36.4% | $123.5M+6.7% | $115.7M-1.5% | $117.5M-5.0% | $123.7M+0.2% | $123.4M+39.6% | $88.4M+30.0% | $68.0M+198.6% | $22.8M |
| Accounts Receivable | $160.5M+4.9% | $153.0M-11.1% | $172.0M+18.8% | $144.7M+11.9% | $129.4M+22.0% | $106.1M-20.0% | $132.6M-4.0% | $138.1M+4.1% | $132.7M+10.2% | $120.4M-2.3% | $123.2M-18.3% | $150.8M+52.0% | $99.2M+53.4% | $64.7M | N/A |
| Goodwill | $101.6M+2.5% | $99.1M-1.0% | $100.1M+54.0% | $65.0M-0.3% | $65.1M+82.5% | $35.7M-90.7% | $385.7M0.0% | $385.8M-0.3% | $387.1M+0.4% | $385.6M+0.5% | $383.9M-71.0% | $1.3B+10.7% | $1.2B+45.4% | $822.5M+3138.2% | $25.4M |
| Total Liabilities | $230.9M-2.5% | $236.8M-4.9% | $249.1M-17.1% | $300.4M-6.5% | $321.2M+39.4% | $230.4M+3.0% | $223.7M-8.8% | $245.3M-0.1% | $245.6M+7.7% | $228.0M+2.2% | $223.2M-38.7% | $363.9M+28.8% | $282.4M+77.2% | $159.4M+314.4% | $38.5M |
| Current Liabilities | $163.0M-2.5% | $167.2M-5.2% | $176.4M-16.2% | $210.7M+0.1% | $210.5M+59.3% | $132.2M-17.4% | $159.9M-9.0% | $175.8M+7.6% | $163.3M-0.8% | $164.6M-4.7% | $172.7M-31.1% | $250.6M+86.0% | $134.7M+42.7% | $94.4M+224.1% | $29.1M |
| Long-Term Debt | N/A | N/A | N/A | N/A | N/A | N/A | N/A | $22.0M-18.9% | $27.1M+21.8% | $22.3M | N/A | N/A | N/A | N/A | N/A |
| Total Equity | $842.9M+6.3% | $793.0M-10.4% | $884.8M-7.8% | $959.4M+0.4% | $956.0M+25.9% | $759.4M-34.4% | $1.2B+1.3% | $1.1B+0.8% | $1.1B-0.3% | $1.1B-4.4% | $1.2B-53.0% | $2.5B+1.2% | $2.5B+59.1% | $1.6B+757.4% | $183.3M |
| Retained Earnings | -$2.4B-4.5% | -$2.3B-5.5% | -$2.2B-5.9% | -$2.1B-1.4% | -$2.0B-3.1% | -$2.0B-28.8% | -$1.5B-0.7% | -$1.5B-0.5% | -$1.5B-2.7% | -$1.5B-5.5% | -$1.4B-4053.1% | -$33.9M-139.6% | $85.5M-24.0% | $112.5M+8.2% | $104.0M |
SSYS Cash Flow Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.
| Metric | FY25 | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $15.1M+93.5% | $7.8M+112.7% | -$61.6M+18.2% | -$75.4M-310.5% | $35.8M+28.9% | $27.8M+348.4% | -$11.2M-117.6% | $63.7M+3.2% | $61.7M-0.3% | $61.9M+382.6% | -$21.9M-258.6% | $13.8M-56.9% | $32.0M+2043.8% | $1.5M-93.4% | $22.5M |
| Capital Expenditures | $22.1M+103.4% | $10.9M-19.8% | $13.6M-0.6% | $13.6M-45.4% | $25.0M-7.3% | $26.9M+20.2% | $22.4M-4.0% | $23.4M+4.7% | $22.3M-50.6% | $45.1M-46.5% | $84.3M+39.3% | $60.5M+81.8% | $33.3M+176.0% | $12.1M-6.2% | $12.8M |
| Free Cash Flow | -$7.0M-128.6% | -$3.0M+95.9% | -$75.2M+15.5% | -$89.0M-921.2% | $10.8M+1162.3% | $859K+102.6% | -$33.6M-183.3% | $40.4M+2.4% | $39.4M+134.7% | $16.8M+115.8% | -$106.2M-127.5% | -$46.7M-3643.5% | -$1.2M+88.2% | -$10.6M-209.3% | $9.7M |
| Investing Cash Flow | -$112.2M-657.3% | -$14.8M-286.5% | -$3.8M+46.8% | -$7.2M+97.5% | -$291.2M-453.3% | -$52.6M+24.3% | -$69.5M-1073.2% | $7.1M+125.7% | -$27.8M+60.4% | -$70.1M+24.7% | -$93.1M | N/A | N/A | $81.5M+310.1% | -$38.8M |
| Financing Cash Flow | $118.0M+3659.8% | -$3.3M-118.6% | -$1.5M+45.3% | -$2.8M-101.2% | $227.3M+99597.8% | $228K+101.0% | -$22.0M-645.8% | -$3.0M-127.6% | $10.7M-58.5% | $25.8M+138.5% | -$67.0M | N/A | N/A | $30.5M+247.7% | $8.8M |
Not reported in any period shown, so not listed: Dividends Paid, Share Buybacks.
SSYS Financial Ratios
Margins and returns are percentages; the remaining ratios are unitless multiples.
| Metric | FY25 | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 41.2%-3.6pp | 44.9%+2.3pp | 42.5%+0.1pp | 42.4%-0.4pp | 42.8%+0.7pp | 42.1%-7.2pp | 49.3%+0.3pp | 49.0%+0.8pp | 48.3%+1.1pp | 47.2%+32.5pp | 14.7%-33.6pp | 48.3%+1.6pp | 46.7%-4.4pp | 51.1%-1.8pp | 52.9% |
| Operating Margin | -13.2%+1.8pp | -15.0%-1.0pp | -14.0%-5.2pp | -8.8%+4.3pp | -13.0%+74.5pp | -87.5%-85.7pp | -1.8%-0.5pp | -1.3%+3.2pp | -4.6%+8.3pp | -12.9% | -197.3% | -19.8%-13.8pp | -6.0%-13.9pp | 8.0%-10.7pp | 18.6% |
| Net Margin | -18.9%+2.1pp | -21.0%-1.4pp | -19.6%-15.2pp | -4.5%+5.8pp | -10.2%+75.0pp | -85.2%-83.5pp | -1.7%-0.1pp | -1.7%+4.3pp | -6.0%+5.5pp | -11.5% | -197.3% | -15.9%-10.4pp | -5.6%-9.5pp | 3.9%-9.3pp | 13.2% |
| Return on Equity | -12.4%+2.8pp | -15.2%-1.3pp | -13.9%-10.9pp | -3.0%+3.5pp | -6.5%+52.0pp | -58.4%-57.5pp | -0.9%0.0pp | -1.0%+2.6pp | -3.5%+3.3pp | -6.8%+108.7pp | -115.5%-110.8pp | -4.7%-3.6pp | -1.1%-1.6pp | 0.5%-10.7pp | 11.3% |
| Return on Assets | -9.7%+2.0pp | -11.7%-0.8pp | -10.8%-8.5pp | -2.3%+2.6pp | -4.9%+40.0pp | -44.8%-44.0pp | -0.8%0.0pp | -0.8%+2.1pp | -2.9%+2.8pp | -5.7%+91.4pp | -97.1%-92.9pp | -4.1%-3.1pp | -1.0%-1.5pp | 0.5%-8.8pp | 9.3% |
| Current Ratio | 3.57+0.5x | 3.07-0.1x | 3.17-0.1x | 3.32-0.5x | 3.80-0.4x | 4.24+0.1x | 4.12+0.2x | 3.89+0.1x | 3.77+0.4x | 3.36+0.2x | 3.170.0x | 3.18-3.1x | 6.32+2.9x | 3.42+0.2x | 3.20 |
| Debt-to-Equity | 0.270.0x | 0.300.0x | 0.280.0x | 0.310.0x | 0.340.0x | 0.30+0.1x | 0.19+0.2x | 0.020.0x | 0.020.0x | 0.02-0.2x | 0.190.0x | 0.140.0x | 0.110.0x | 0.10-0.1x | 0.21 |
| FCF Margin | -1.3%-0.7pp | -0.5%+11.5pp | -12.0%+1.7pp | -13.7%-15.5pp | 1.8%+1.6pp | 0.2%+5.4pp | -5.3%-11.4pp | 6.1%+0.2pp | 5.9%+3.4pp | 2.5%+17.8pp | -15.3%-9.0pp | -6.2%-6.0pp | -0.3%+4.7pp | -4.9%-11.1pp | 6.2% |
Reported as filed but not readable as a share of revenue in the periods where the ratio runs further from zero than a revenue base allows; no change figure is given where either compared period is one of those: Operating Margin, Net Margin.
Similar Companies
Where Stratasys Ltd Ranks
Frequently Asked Questions
What is Stratasys Ltd's annual revenue?
Stratasys Ltd (SSYS) reported $551.1M in total revenue for fiscal year 2025. This represents a -3.7% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.
How fast is Stratasys Ltd's revenue growing?
Stratasys Ltd (SSYS) revenue declined by 3.7% year-over-year, from $572.5M to $551.1M in fiscal year 2025.
Is Stratasys Ltd profitable?
No, Stratasys Ltd (SSYS) reported a net income of -$104.3M in fiscal year 2025, with a net profit margin of -18.9%.
What is Stratasys Ltd's EBITDA?
Stratasys Ltd (SSYS) had EBITDA of -$29.3M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.
What is Stratasys Ltd's gross margin?
Stratasys Ltd (SSYS) had a gross margin of 41.2% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.
What is Stratasys Ltd's operating margin?
Stratasys Ltd (SSYS) had an operating margin of -13.2% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.
What is Stratasys Ltd's net profit margin?
Stratasys Ltd (SSYS) had a net profit margin of -18.9% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.
What is Stratasys Ltd's return on equity (ROE)?
Stratasys Ltd (SSYS) has a return on equity of -12.4% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.
What is Stratasys Ltd's free cash flow?
Stratasys Ltd (SSYS) recorded an outflow of $7.0M in free cash flow during fiscal year 2025. This represents a -128.6% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.
What is Stratasys Ltd's operating cash flow?
Stratasys Ltd (SSYS) generated $15.1M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.
What are Stratasys Ltd's total assets?
Stratasys Ltd (SSYS) had $1.1B in total assets as of fiscal year 2025, including both current and long-term assets.
What are Stratasys Ltd's capital expenditures?
Stratasys Ltd (SSYS) invested $22.1M in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.
How much does Stratasys Ltd spend on research and development?
Stratasys Ltd (SSYS) invested $77.3M in research and development during fiscal year 2025.
What is Stratasys Ltd's current ratio?
Stratasys Ltd (SSYS) had a current ratio of 3.57 as of fiscal year 2025, which is generally considered healthy.
What is Stratasys Ltd's debt-to-equity ratio?
Stratasys Ltd (SSYS) had a debt-to-equity ratio of 0.27 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.
What is Stratasys Ltd's return on assets (ROA)?
Stratasys Ltd (SSYS) had a return on assets of -9.7% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.
What is Stratasys Ltd's Altman Z-Score?
Stratasys Ltd (SSYS) has an Altman Z-Score of -0.46, placing it in the Distress Zone (elevated bankruptcy risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.
What is Stratasys Ltd's Piotroski F-Score?
Stratasys Ltd (SSYS) has a Piotroski F-Score of 4 out of 8 computable signals; 1 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.
Are Stratasys Ltd's earnings high quality?
Stratasys Ltd (SSYS) reported a net loss of $104.3M while generating $15.1M in operating cash flow. Operations generated cash despite the loss, but with no positive earnings behind it, the ratio between the two carries no quality signal. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.
How financially healthy is Stratasys Ltd?
Stratasys Ltd (SSYS) scores 45 out of 100 on our Financial Health Score, indicating moderate standing within its operating companies peer group. The score is a 0-100 composite of six dimensions (Profitability, Growth, Leverage, Liquidity, Cash Flow, Returns), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.